Psoriasis and COVID ‐19: A narrative review with treatment considerations
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psoriasis and
COVID
‐19: A narrative review with treatment considerations
Authors
Keywords
-
Journal
Dermatologic Therapy
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-17
DOI
10.1111/dth.13858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
- (2020) Cong Ye et al. ANNALS OF THE RHEUMATIC DISEASES
- The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
- (2020) P. Gisondi et al. BRITISH JOURNAL OF DERMATOLOGY
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Non‐complicated evolution of COVID ‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab
- (2020) M. Valenti et al. Dermatologic Therapy
- Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?
- (2020) Bruno Mégarbane et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears
- (2020) Matteo Megna et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A survey of psoriasis patients on biologics during COVID-19: a single centre experience
- (2020) Martina Burlando et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment
- (2020) Muskaan Sachdeva et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey
- (2020) Yehong Kuang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy
- (2020) Andrea Carugno et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- COVID-19 and immunomodulator/immunosuppressant use in dermatology
- (2020) Kyla N. Price et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy)
- (2020) L. Atzori et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Improvement of SARS‐CoV2 symptoms following Guselkumab injection in a psoriatic patient
- (2020) F. Benhadou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs
- (2020) A. Conti et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- SARS‐CoV‐2 infection in a psoriatic patient treated with IL‐17 inhibitor
- (2020) R. Balestri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
- (2020) F. Messina et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
- (2019) Erica D. Dommasch et al. JAMA Dermatology
- Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Zenas Z.N. Yiu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice
- (2016) Shi-Wei Huang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
- (2016) Jonathan West et al. PLoS One
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Chloroquine Promotes IL-17 Production by CD4+T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells
- (2014) André Said et al. JOURNAL OF IMMUNOLOGY
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Psychosomatic paradigms in psoriasis: Psoriasis, stress and mental health
- (2013) TS Sathyanarayana Rao et al. Indian Journal of Psychiatry
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started